(0.32%) 5 116.41 points
(0.32%) 38 361 points
(0.36%) 15 985 points
(-0.86%) $83.13
(5.93%) $2.04
(0.37%) $2 355.90
(0.47%) $27.67
(4.02%) $959.15
(-0.22%) $0.933
(-0.37%) $10.98
(-0.54%) $0.796
(1.69%) $93.43
Live Chart Being Loaded With Signals
Aziyo Biologics, Inc., a regenerative medicine company, focuses on the development of regenerative medical products to address the implantable electronic device/cardiovascular, orthopedic/spinal repair, and soft tissue reconstruction markets...
Stats | |
---|---|
本日の出来高 | 8 103.00 |
平均出来高 | 432 734 |
時価総額 | 24.21M |
EPS | $0 ( 2024-03-20 ) |
次の収益日 | ( $0 ) 2024-05-08 |
Last Dividend | $0 ( N/A ) |
Next Dividend | $0 ( N/A ) |
P/E | -0.683 |
ATR14 | $0.182 (13.09%) |
Date | Person | Action | Amount | type |
---|---|---|---|---|
2023-12-28 | Highcape Capital, Llc | Sell | 1 436 077 | Class A Common Stock |
2023-12-28 | Highcape Capital, Llc | Sell | 2 154 116 | Warrants (right to buy) |
2023-12-28 | Highcape Capital, L.p. | Sell | 1 436 077 | Class A Common Stock |
2023-12-28 | Highcape Capital, L.p. | Sell | 2 154 116 | Warrants (right to buy) |
2021-09-21 | Highcape Capital, Llc | Buy | 2 837 128 | Class A Common Stock |
INSIDER POWER |
---|
-80.21 |
Last 95 transactions |
Buy: 17 583 923 | Sell: 9 483 030 |
ボリューム 相関
Aziyo Biologics, Inc. 相関
10 最も正の相関 | |
---|---|
CWBC | 0.953 |
WTFCP | 0.946 |
PWOD | 0.945 |
UCBIO | 0.944 |
ATLO | 0.943 |
NWFL | 0.939 |
WSBCP | 0.939 |
RMRM | 0.938 |
BIRD | 0.936 |
PTRS | 0.933 |
10 最も負の相関 | |
---|---|
BOCH | -0.968 |
DRNA | -0.962 |
MMAC | -0.951 |
SUMO | -0.922 |
SOPH | -0.919 |
NETE | -0.914 |
ALBO | -0.913 |
SMED | -0.911 |
CMPI | -0.906 |
SHSP | -0.897 |
知っていましたか?
相関は、2つの変数間の関係を説明する統計的指標です。相関係数は-1から1までの値を取り、-1は完全な負の相関(1つの変数が増加すると、もう一方は減少する)、1は完全な正の相関(1つの変数が増加すると、もう一方も増加する)、0は相関がないことを示します(変数間に関係がない)。
相関は、株式だけでなく、どの2つの変数間の関係にも適用できます。これは、金融、経済学、心理学などの分野で一般的に使用されています。
Aziyo Biologics, Inc. 相関 - 通貨/商品
Aziyo Biologics, Inc. 財務諸表
Annual | 2022 |
収益: | $49.19M |
総利益: | $19.22M (39.08 %) |
EPS: | $-2.38 |
FY | 2022 |
収益: | $49.19M |
総利益: | $19.22M (39.08 %) |
EPS: | $-2.38 |
FY | 2021 |
収益: | $47.39M |
総利益: | $19.02M (40.14 %) |
EPS: | $-8.71 |
FY | 2020 |
収益: | $42.68M |
総利益: | $20.56M (48.17 %) |
EPS: | $-8.88 |
Financial Reports:
No articles found.
Aziyo Biologics, Inc.
Aziyo Biologics, Inc., a regenerative medicine company, focuses on the development of regenerative medical products to address the implantable electronic device/cardiovascular, orthopedic/spinal repair, and soft tissue reconstruction markets. It offers CanGaroo that combines the envelope with antibiotics and is designed to reduce the risk of infection following surgical implantation of an electronic device. The company also provides cardiovascular products, such as ProxiCor for use as an intracardiac patch or pledget for tissue repairs; Tyke for use in neonates and infants to repair pericardial structures; and VasCure, a patch material to repair or reconstruct the peripheral vasculature, including the carotid, renal, iliac, femoral, and tibial blood vessels for cardiovascular, vascular, and general surgeons. In addition, it offers Fiber VBM, ViBone, and OsteGro V that are human tissue-derived bone allografts designed to protect and preserve native bone cells; and SimpliDerm, a pre-hydrated HADM designed to repair or replacement of damaged or inadequate integumental tissues. Further, the company provides contract manufacturing services for various products to corporate customers. It sells its products to hospitals and other healthcare facilities through its direct sales force, commercial partners, and independent sales agents. The company was incorporated in 2015 and is headquartered in Silver Spring, Maryland.
について ライブシグナル
このページで提示されるライブシグナルは、NA を買う時や売る時を判断するのに役立ちます。シグナルには1分以上の遅延があります。市場シグナルには誤りやミスの可能性があるため、ライブ取引シグナルは決定的ではなく、getagraph.comはこれらのシグナルに基づく任意の行動について責任を負いません。詳細については、利用規約で説明されているように、技術分析指標に基づいています。